Top Markets
Coin of the day
GridAI Technologies Corp. GridAI Technologies Corp.

GridAI Technologies Corp.

GRDX
Rang in Aktien #31271
GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical... GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical enterprise primarily dedicated to developing precise, locally-acting treatments for various digestive system ailments. Its core activity involves researching and advancing therapeutic solutions specifically designed for patients with gastrointestinal diseases. The company's pipeline features several key drug candidates, including Latiglutenase, Capeserod, Adrulipase, and Niclosamide. GridAI Technologies was established on January 30, 2014, and maintains its principal offices in Boca Raton, Florida.
Aktienkurs
$4.02
Marktkapitalisierung
$13.51M
Veränderung (1 Tag)
1.77%
Veränderung (1 Jahr)
86.11%
Land
US
Handel GridAI Technologies Corp. (GRDX)

Kategorie

Kursverlauf für GridAI Technologies Corp. (GRDX)
Höchster Schlusskurs: $3.43 am 2026-08-01

Niedrigster Schlusskurs: $636.55K am 2016-10-01
Kursverlauf der Aktie von GridAI Technologies Corp. von 2016 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 26.26%
2025 49.22%
2024 -88.09%
2023 -94.42%
2022 -98.54%
2021 -81.30%
2020 -9.98%
2019 -42.81%
2018 -49.10%
2017 -28.62%
2016 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$525.32 34.74%
US
$996.61 50.70%
NL
$111.31 -36.83%
AU
$736.64 6.99%
CH
$257.28 12.80%
BE